![Page 1: Designing of anti-counterfeiting & Compliance solutions in a](https://reader036.vdocuments.site/reader036/viewer/2022081519/56813731550346895d9ebe4c/html5/thumbnails/1.jpg)
A Bilcare Singapore Initiative Bilcare © 2007 Privileged Information
The Oxford Conference on Innovation & Technology Transfer for Global Health, Oxford, U.K. September 9 – 13, 2007
1
Designing of anti-counterfeiting & Compliance solutions
in a comprehensive patient centric healthcare system
Prabuddha Ganguli, Ph.D.CEO – Vision IPR &Director - Bilcare Singapore
And
Praful Naik, Ph.D.CSO - Bilcare Limited
![Page 2: Designing of anti-counterfeiting & Compliance solutions in a](https://reader036.vdocuments.site/reader036/viewer/2022081519/56813731550346895d9ebe4c/html5/thumbnails/2.jpg)
A Bilcare Singapore Initiative Bilcare © 2007 Privileged Information
The Oxford Conference on Innovation & Technology Transfer for Global Health, Oxford, U.K. September 9 – 13, 2007
2
BackdropGlobal Pharma industry is undergoing a major transformation in all quarters of its value chain
– Legitimate competition involving emerging technologies
– Innovation processes are getting expensive–
– IPR & public policy taking centre stage
– Clandestine industry of counterfeiting is a major barrier to genuine access to innovations & healthcare
![Page 3: Designing of anti-counterfeiting & Compliance solutions in a](https://reader036.vdocuments.site/reader036/viewer/2022081519/56813731550346895d9ebe4c/html5/thumbnails/3.jpg)
A Bilcare Singapore Initiative Bilcare © 2007 Privileged Information
The Oxford Conference on Innovation & Technology Transfer for Global Health, Oxford, U.K. September 9 – 13, 2007
3
Impact of Counterfeit
• Growing menace in developing & least developed countries– Revenue Loss – from 10% to 30%
• Contribution Loss – almost equals to industry profit
• Brand credibility ???
• Developed World also significantly impacted
![Page 4: Designing of anti-counterfeiting & Compliance solutions in a](https://reader036.vdocuments.site/reader036/viewer/2022081519/56813731550346895d9ebe4c/html5/thumbnails/4.jpg)
A Bilcare Singapore Initiative Bilcare © 2007 Privileged Information
The Oxford Conference on Innovation & Technology Transfer for Global Health, Oxford, U.K. September 9 – 13, 2007
4
Perils of Counterfeit on Healthcare
• look-alikes with “variable to no efficacy” are detrimental / fatal
• Re-labeling/packaging of rejects/expired drugs: fairly common practice
• Innovations in anti-counterfeiting: non-transparent for the consumer
• Current Covert & Overt Technologies are open ended & generic– eg.: Ineffectiveness of Holograms
• Track & Trace: Implementation challenges & not fool-proof in isolation – eg.: RFID
![Page 5: Designing of anti-counterfeiting & Compliance solutions in a](https://reader036.vdocuments.site/reader036/viewer/2022081519/56813731550346895d9ebe4c/html5/thumbnails/5.jpg)
A Bilcare Singapore Initiative Bilcare © 2007 Privileged Information
The Oxford Conference on Innovation & Technology Transfer for Global Health, Oxford, U.K. September 9 – 13, 2007
5
Challenges• Counterfeit is increasingly recognized as a key challenge as it leads to
– Non-Compliance resulting in frequent change of prescription; drug resistance
– secondary care leading to significant increase in healthcare management cost
• Medicine as total cure recognized as Myth
– Imbalance in diet and fitness management are major contributing factors
• Solutions must
– Empower consumer to participate in the global action on anti-counterfeiting– Be Commercially sustainable & yet simple for operability by the consumer– Be capable of addressing multiple concerns
![Page 6: Designing of anti-counterfeiting & Compliance solutions in a](https://reader036.vdocuments.site/reader036/viewer/2022081519/56813731550346895d9ebe4c/html5/thumbnails/6.jpg)
A Bilcare Singapore Initiative Bilcare © 2007 Privileged Information
The Oxford Conference on Innovation & Technology Transfer for Global Health, Oxford, U.K. September 9 – 13, 2007
6
Challenges…• Avoidable Complications & Hospitalization
• Enhanced burden of healthcare costs on Nations
• Anti-Counterfeit – Who should tackle?
– Producer, Regulator, Patient, Pharmacist or the Doctor? – Government, Healthcare Organizations, Insurance Cos.?
“Means & process to facilitate Collaborative efforts of all stake holders”
![Page 7: Designing of anti-counterfeiting & Compliance solutions in a](https://reader036.vdocuments.site/reader036/viewer/2022081519/56813731550346895d9ebe4c/html5/thumbnails/7.jpg)
A Bilcare Singapore Initiative Bilcare © 2007 Privileged Information
The Oxford Conference on Innovation & Technology Transfer for Global Health, Oxford, U.K. September 9 – 13, 2007
7
• Clinical Research & Development of new medicines / therapies
– Impact of Non - Compliance
– Real time patient feedback
– Timely professional interventions
“Means & process to facilitate Robust Clinical Research Management”
Challenges…
![Page 8: Designing of anti-counterfeiting & Compliance solutions in a](https://reader036.vdocuments.site/reader036/viewer/2022081519/56813731550346895d9ebe4c/html5/thumbnails/8.jpg)
A Bilcare Singapore Initiative Bilcare © 2007 Privileged Information
The Oxford Conference on Innovation & Technology Transfer for Global Health, Oxford, U.K. September 9 – 13, 2007
8
Patient
Doctor
Care Giver
Pharmacy
Hospital
Insurer
Stake Holders
Manufacturer
The Current Healthcare Scenario
![Page 9: Designing of anti-counterfeiting & Compliance solutions in a](https://reader036.vdocuments.site/reader036/viewer/2022081519/56813731550346895d9ebe4c/html5/thumbnails/9.jpg)
A Bilcare Singapore Initiative Bilcare © 2007 Privileged Information
The Oxford Conference on Innovation & Technology Transfer for Global Health, Oxford, U.K. September 9 – 13, 2007
9
Bilcare’s Approach
Patents Pending
![Page 10: Designing of anti-counterfeiting & Compliance solutions in a](https://reader036.vdocuments.site/reader036/viewer/2022081519/56813731550346895d9ebe4c/html5/thumbnails/10.jpg)
A Bilcare Singapore Initiative Bilcare © 2007 Privileged Information
The Oxford Conference on Innovation & Technology Transfer for Global Health, Oxford, U.K. September 9 – 13, 2007
10
PatientDoctor
![Page 11: Designing of anti-counterfeiting & Compliance solutions in a](https://reader036.vdocuments.site/reader036/viewer/2022081519/56813731550346895d9ebe4c/html5/thumbnails/11.jpg)
A Bilcare Singapore Initiative Bilcare © 2007 Privileged Information
The Oxford Conference on Innovation & Technology Transfer for Global Health, Oxford, U.K. September 9 – 13, 2007
11
PatientDoctor
Interactive Companion
Device
![Page 12: Designing of anti-counterfeiting & Compliance solutions in a](https://reader036.vdocuments.site/reader036/viewer/2022081519/56813731550346895d9ebe4c/html5/thumbnails/12.jpg)
A Bilcare Singapore Initiative Bilcare © 2007 Privileged Information
The Oxford Conference on Innovation & Technology Transfer for Global Health, Oxford, U.K. September 9 – 13, 2007
12
PatientDoctor
HealthcareKnowledge
Management System
Interactive Companion
Device
![Page 13: Designing of anti-counterfeiting & Compliance solutions in a](https://reader036.vdocuments.site/reader036/viewer/2022081519/56813731550346895d9ebe4c/html5/thumbnails/13.jpg)
A Bilcare Singapore Initiative Bilcare © 2007 Privileged Information
The Oxford Conference on Innovation & Technology Transfer for Global Health, Oxford, U.K. September 9 – 13, 2007
13
PatientDoctor
ComplianceSupport
Interactive Companion
Device
HealthcareKnowledge
Management System
![Page 14: Designing of anti-counterfeiting & Compliance solutions in a](https://reader036.vdocuments.site/reader036/viewer/2022081519/56813731550346895d9ebe4c/html5/thumbnails/14.jpg)
A Bilcare Singapore Initiative Bilcare © 2007 Privileged Information
The Oxford Conference on Innovation & Technology Transfer for Global Health, Oxford, U.K. September 9 – 13, 2007
14
PatientDoctor
ComplianceSupport
Anti - counterfeitSupport
Interactive Companion
Device
HealthcareKnowledge
Management System
![Page 15: Designing of anti-counterfeiting & Compliance solutions in a](https://reader036.vdocuments.site/reader036/viewer/2022081519/56813731550346895d9ebe4c/html5/thumbnails/15.jpg)
A Bilcare Singapore Initiative Bilcare © 2007 Privileged Information
The Oxford Conference on Innovation & Technology Transfer for Global Health, Oxford, U.K. September 9 – 13, 2007
15
PatientDoctor
ComplianceSupport
Anti - counterfeitSupport
Interactive Companion
Device
HealthcareKnowledge
Management System
![Page 16: Designing of anti-counterfeiting & Compliance solutions in a](https://reader036.vdocuments.site/reader036/viewer/2022081519/56813731550346895d9ebe4c/html5/thumbnails/16.jpg)
A Bilcare Singapore Initiative Bilcare © 2007 Privileged Information
The Oxford Conference on Innovation & Technology Transfer for Global Health, Oxford, U.K. September 9 – 13, 2007
16
Pharmacy
ComplianceSupport
Care giver
Anti - counterfeitSupport
PatientDoctor
Insurer
Manufacturer
Hospital
National Health System
Distribution
IntegratedInteractive Companion
Device
HealthcareKnowledge
Management System
![Page 17: Designing of anti-counterfeiting & Compliance solutions in a](https://reader036.vdocuments.site/reader036/viewer/2022081519/56813731550346895d9ebe4c/html5/thumbnails/17.jpg)
A Bilcare Singapore Initiative Bilcare © 2007 Privileged Information
The Oxford Conference on Innovation & Technology Transfer for Global Health, Oxford, U.K. September 9 – 13, 2007
17
Key Deliverables• Registration & Exclusivity of the Companion device
• Authentication of medicine
• User compliance inclusive of Diet & Fitness
• Online patient feedback
• E- prescription
• Generation and transmission of customized reports
• Secured data & Information for stake holders
• Real-time data in raw and analyzed form
![Page 18: Designing of anti-counterfeiting & Compliance solutions in a](https://reader036.vdocuments.site/reader036/viewer/2022081519/56813731550346895d9ebe4c/html5/thumbnails/18.jpg)
A Bilcare Singapore Initiative Bilcare © 2007 Privileged Information
The Oxford Conference on Innovation & Technology Transfer for Global Health, Oxford, U.K. September 9 – 13, 2007
18
Key to SuccessFor effective & successful implementation
• Participation of major stakeholders
• Involvement of regulatory & governing agencies – WHO, NHS & their likes
• Test implementation in a region
• Planned transfer of technology
• Blending of various local regional requirements
• Awareness & Training support